Human Epidermal Growth Factor Receptor 2 Loss Following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer.
Gouda MA, Gonugunta A, Dumbrava EE, Yap TA, Rodon J, Piha-Paul SA, Pohlmann PR, Damodaran S, Murthy R, Valero V, Mouabbi J, Tripathy D, Sahin AA, Chen H, Meric-Bernstam F.
Gouda MA, et al. Among authors: chen h.
Clin Cancer Res. 2025 Jan 22. doi: 10.1158/1078-0432.CCR-24-3468. Online ahead of print.
Clin Cancer Res. 2025.
PMID: 39841861